Published in Int J Lab Hematol on October 05, 2011
Reply: ICSH recommendations for the measurement of hemoglobin A2. Int J Lab Hematol (2012) 1.06
Human fetal globin gene expression is regulated by LYAR. Nucleic Acids Res (2014) 0.93
Carrier screening for inherited haemoglobin disorders among secondary school students and young adults in Latium, Italy. J Community Genet (2013) 0.90
Two decades of pre-marital screening for beta-thalassemia in central Iran. J Community Genet (2013) 0.83
Hemoglobin A2 values in sickle cell disease patients quantified by high performance liquid chromatography and the influence of alpha thalassemia. Rev Bras Hematol Hemoter (2015) 0.78
Rapid detection of pathological mutations and deletions of the haemoglobin beta gene (HBB) by High Resolution Melting (HRM) analysis and Gene Ratio Analysis Copy Enumeration PCR (GRACE-PCR). BMC Med Genet (2016) 0.75
EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. Eur J Hum Genet (2014) 0.75
Comparative analysis of cellulose acetate hemoglobin electrophoresis and high performance liquid chromatography for quantitative determination of hemoglobin A2. Blood Res (2015) 0.75
Spectrum of alpha-globin gene mutations among premarital Baluch couples in southeastern Iran. Int J Hematol Oncol Stem Cell Res (2015) 0.75
Haemoglobin A₂ analysis. Int J Lab Hematol (2012) 0.75
Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A (2001) 2.77
Two different molecular organizations account for the single alpha-globin gene of the alpha-thalassemia-2 genotype. J Clin Invest (1980) 2.38
The relationship context of contraceptive use at first intercourse. Fam Plann Perspect (2000) 2.24
[The 'Anemia in the midwife practice' standard issued by the Royal Dutch Organisation of Midwives: a risk of not recognizing iron deficiency and hemoglobinopathy]. Ned Tijdschr Geneeskd (2002) 2.13
Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med (2000) 2.07
Relationship between neonatal screening results by HPLC and the number of α-thalassaemia gene mutations; consequences for the cut-off value. J Med Screen (2011) 2.05
Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet (2005) 1.96
Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest (2007) 1.85
Primary renal non-Hodgkin's lymphoma. An unusual extranodal site. Cancer (1995) 1.82
Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients. Blood Cells Mol Dis (2008) 1.63
Heterozygous beta-thalassemia: relationship between the hematological phenotype and the type of beta-thalassemia mutation. Am J Hematol (1992) 1.62
Albuminuria in Afro-Caribbeans with Type 2 diabetes mellitus: is the sickle cell trait a risk factor? Diabet Med (2004) 1.59
Quality of life in thalassemia. Ann N Y Acad Sci (2005) 1.58
The addition of continuous intravenous infusion of ketorolac to a patient-controlled analgetic morphine regime reduced postoperative myocardial ischemia in patients undergoing elective total hip or knee arthroplasty. Anesth Analg (1997) 1.52
Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methods. Blood Cells Mol Dis (1996) 1.51
Detection of anti-lipoarabinomannan antibodies for the diagnosis of active tuberculosis. Int J Tuberc Lung Dis (1998) 1.50
Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine? Pharmacopsychiatry (2002) 1.47
The disappearance of fetal and donor red blood cells in alloimmunised pregnancies: a reappraisal. Br J Obstet Gynaecol (1997) 1.44
A three-outcome design for phase II clinical trials. Control Clin Trials (2001) 1.42
[Acute anaemia in a Vietnamese patient with alpha-thalassaemia and a parvovirus infection]. Ned Tijdschr Geneeskd (2006) 1.40
A new strategy for prenatal diagnosis of homozygous alpha(0)-thalassemia. Ultrasound Obstet Gynecol (2006) 1.40
Efficient nonlinear light emission of single gold optical antennas driven by few-cycle near-infrared pulses. Phys Rev Lett (2009) 1.36
Membrane phospholipid asymmetry in human thalassemia. Blood (1998) 1.36
Preimplantation diagnosis of thalassemias. J Assist Reprod Genet (1998) 1.35
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations. Leukemia (2010) 1.34
Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations. Int J Lab Hematol (2009) 1.27
Mitochondrial DNA polymorphisms in Thailand. J Hum Genet (2001) 1.26
The molecular basis of Hb H disease in Turkey. Hemoglobin (1997) 1.24
Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients. Proc Natl Acad Sci U S A (2000) 1.22
Sickle cell membranes and oxidative damage. Biochem J (1986) 1.20
Asymmetrically primed selective amplification/temperature shift fluorescence polymerase chain reaction to detect the hemoglobin Constant Spring mutation. Blood (1991) 1.20
Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer. Aliment Pharmacol Ther (2013) 1.20
Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab (1998) 1.18
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol (2005) 1.16
Hemoglobinopathies in Southeast Asia. Hemoglobin (1987) 1.16
alpha-thalassemia in the United Arab Emirates. Acta Haematol (1998) 1.15
The involvement of Alu repeats in recombination events at the alpha-globin gene cluster: characterization of two alphazero-thalassaemia deletion breakpoints. Hum Genet (1997) 1.15
An address-event vision sensor for multiple transient object detection. IEEE Trans Biomed Circuits Syst (2007) 1.13
Acute myeloid leukemia with minimal differentiation. A multiple parameter study. Am J Clin Pathol (1998) 1.13
Denaturing gradient gel electrophoresis and direct sequencing of PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassaemia. Br J Haematol (1990) 1.13
Fatal arteritis due to Pythium insidiosum infection in patients with thalassaemia. Trans R Soc Trop Med Hyg (1993) 1.12
Deep vein thrombosis and changes in coagulation and fibrinolysis after gynaecological operations in Chinese: the effect of oral contraceptives and malignant disease. Br J Haematol (1980) 1.11
Variation of CNV distribution in five different ethnic populations. Cytogenet Genome Res (2007) 1.10
Cerebellar dysmetria at the elbow, wrist, and fingers. J Neurophysiol (1991) 1.09
Effect of environmental factors and gender on the heritability of bone mineral density and bone size. Ann Hum Genet (2006) 1.09
Evaluation of a prenatal screening procedure for beta-thalassaemia carriers in a Chinese population based on the mean corpuscular volume (MCV). Prenat Diagn (1985) 1.08
Inhibition of hemin-induced hemolysis by desferrioxamine: binding of hemin to red cell membranes and the effects of alteration of membrane sulfhydryl groups. Biochim Biophys Acta (1992) 1.06
The effect of erythroid hyperplasia on iron balance. Blood (1988) 1.06
Prevalence and molecular heterogeneity of alfa+ thalassemia in two tribal populations from Andhra Pradesh, India. Hum Genet (1988) 1.06
Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH. Biomacromolecules (2001) 1.06
Genetic factors affecting clinical severity in beta-thalassemia syndromes. J Pediatr Hematol Oncol (2000) 1.05
A bone marrow report of absent stainable iron is not diagnostic of iron deficiency. Ann Hematol (2001) 1.05
Molecular and hematologic features of hemoglobin E heterozygotes with different forms of alpha-thalassemia in Thailand. Ann Hematol (2003) 1.04
Successful mismatched sibling cord blood transplant in Hb Bart's disease. Bone Marrow Transplant (2001) 1.04
Urinary thyroxine excretion as index of thyroid function. Lancet (1972) 1.03
Purification and primary structure of ceratotoxin A and B, two antibacterial peptides from the female reproductive accessory glands of the medfly Ceratitis capitata (Insecta:Diptera). Insect Biochem Mol Biol (1993) 1.03
Airway pressure triggered ventilation for preterm neonates. J Perinat Med (1991) 1.02
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. Prostate Cancer Prostatic Dis (2008) 1.02
Hb Adana or alpha 2(59)(E8)Gly-->Asp beta 2, a severely unstable alpha 1-globin variant, observed in combination with the -(alpha)20.5 Kb alpha-thal-1 deletion in two Turkish patients. Am J Hematol (1993) 1.02
Molecular basis of beta-thalassemia in the Maldives. Hemoglobin (1998) 1.01
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. Br J Cancer (2005) 1.01
alpha-Thalassaemia in the population of Cyprus. Br J Haematol (1995) 1.01
Familial lymphedema praecox: Meige's disease. Plast Reconstr Surg (1981) 1.01
Exercise test in muscle channelopathies and other muscle disorders. Muscle Nerve (2000) 1.01
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Endocr Relat Cancer (2005) 1.00
A double-blind comparison of ropivacaine 0.5%, 0.75%, 1.0% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy. Can J Anaesth (1996) 1.00
Regulation of peptide hormone receptors and gonadal steroidogenesis. Recent Prog Horm Res (1980) 0.99
The unusual pathobiology of hemoglobin constant spring red blood cells. Blood (1997) 0.99
Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol Chem (1999) 0.99
Impaired parasite growth and increased susceptibility to phagocytosis of Plasmodium falciparum infected alpha-thalassemia or hemoglobin Constant Spring red blood cells. Am J Clin Pathol (1988) 0.99
Hb H disease in a Turkish family resulting from the interaction of a deletional alpha-thalassaemia-1 and a newly discovered poly A mutation. Br J Haematol (1992) 0.99
The role of haemoglobin A(2) testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol (2009) 0.99
Hematologic and biosynthetic studies in homozygous hemoglobin Constant Spring. J Clin Invest (1984) 0.98
Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels? Diabetes Res Clin Pract (2007) 0.98
Pulmonary artery obstruction in thalassaemia. Southeast Asian J Trop Med Public Health (1980) 0.98
Molecular characterization of Hb S(C) beta-thalassemia in American blacks. Am J Hematol (1991) 0.98
Synchronous intermittent mandatory ventilation modes compared with patient triggered ventilation during weaning. Arch Dis Child Fetal Neonatal Ed (1995) 0.97
Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood (1999) 0.96
Beta-globin gene cluster polymorphisms are strongly associated with severity of HbE/beta(0)-thalassemia. Clin Genet (2007) 0.96
Pulmonary thromboembolism in thalassemic patients. Southeast Asian J Trop Med Public Health (1992) 0.95
Preimplantation diagnosis and HLA typing for haemoglobin disorders. Reprod Biomed Online (2005) 0.95
Red cell deformability, splenic function and anaemia in thalassaemia. Br J Haematol (1999) 0.95
Adult, fetal, and polycystic kidney expression of polycystin, the polycystic kidney disease-1 gene product. Lab Invest (1996) 0.95
Molecular spectrum of beta-thalassemia in the Iranian Province of Hormozgan. Hemoglobin (2001) 0.94
Goal post injuries in soccer. A laboratory and field testing analysis of a preventive intervention. Am J Sports Med (1995) 0.94
After the introduction into the national newborn screening program: who is receiving genetic counseling for hemoglobinopathies in the Netherlands? Public Health Genomics (2013) 0.93
Beta-thalassemia in Thailand. Ann N Y Acad Sci (1990) 0.93
Thalassemia in Thailand. Ann N Y Acad Sci (1980) 0.93
Sequence effect of irinotecan (CPT-11) and topoisomerase II inhibitors in vivo. Cancer Chemother Pharmacol (1998) 0.92
Huntington's disease in Hong Kong Chinese: epidemiology and clinical picture. Clin Exp Neurol (1994) 0.92
A mild type of Hb S-beta(+)-thalassemia [-92(C-->T)] in a Sicilian family. Am J Hematol (1993) 0.92
Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs. Acta Haematol (1994) 0.92
Consistent patterns of allelic loss in natural killer cell lymphoma. Am J Pathol (2000) 0.92
Prevalence of HTLV-III/LAV antibody in selected populations in Thailand. Southeast Asian J Trop Med Public Health (1985) 0.91
Effect of acute myocardial infarction on pituitary-testicular function. Clin Endocrinol (Oxf) (1978) 0.91
Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example. Prenat Diagn (2009) 0.91
The instability of the membrane skeleton in thalassemic red blood cells. Blood (1995) 0.91
Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course. Br J Haematol (1999) 0.91
Homozygous alpha-thalassaemia: clinical presentation, diagnosis and management. A review of 46 cases. Br J Obstet Gynaecol (1985) 0.91